Asosiy kontentga oʻtish
AkademScholar
Mualliflar

Laziz Turaev

Soʻnggi maʼlum muassasa:
Ministry of Health of the Republic of Uzbekistan
ORCID:
0000-0002-8696-1851
2
h-indeks
1
i10-indeksi
18
Iqtiboslar
9
Asarlar
Vaqt boʻyicha

Vaqt boʻyicha tahlil

Iqtibos sharhi

Yillar boʻyicha nashrlar (ustun) va iqtiboslar (chiziq)

  • Nashrlar
  • Iqtiboslar
0134503581020132014201520162017201820192021202220262013: Nashrlar 2, Iqtiboslar 02014: Nashrlar 0, Iqtiboslar 12015: Nashrlar 0, Iqtiboslar 12016: Nashrlar 0, Iqtiboslar 32017: Nashrlar 0, Iqtiboslar 12018: Nashrlar 0, Iqtiboslar 12019: Nashrlar 0, Iqtiboslar 12021: Nashrlar 4, Iqtiboslar 82022: Nashrlar 0, Iqtiboslar 12026: Nashrlar 1, Iqtiboslar 1

Iqtibos tarixi

03581020132014201520162017201820192021202220262013: Iqtiboslar 02014: Iqtiboslar 12015: Iqtiboslar 12016: Iqtiboslar 32017: Iqtiboslar 12018: Iqtiboslar 12019: Iqtiboslar 12021: Iqtiboslar 82022: Iqtiboslar 12026: Iqtiboslar 1

Nashr tarixi

0134520132014201520162017201820192021202220262013: Nashrlar 22014: Nashrlar 02015: Nashrlar 02016: Nashrlar 02017: Nashrlar 02018: Nashrlar 02019: Nashrlar 02021: Nashrlar 42022: Nashrlar 02026: Nashrlar 1

h-indeks evolyutsiyasi

Yillar boʻyicha jamlangan h-indeks

01220132014201520162017201820192021202220262013: h-indeks 02014: h-indeks 12015: h-indeks 12016: h-indeks 12017: h-indeks 12018: h-indeks 12019: h-indeks 12021: h-indeks 12022: h-indeks 22026: h-indeks 2

Eng koʻp iqtibos qilingan asarlar

  1. Multidrug-resistant tuberculosis in Uzbekistan: results of a nationwide survey, 2010 to 2011201315 iqtibos
  2. Scaling Up Molecular Diagnostic Tests for Drug-Resistant Tuberculosis in Uzbekistan from 2012–2019: Are We on the Right Track?20213 iqtibos
  3. Direct comparison of GeneXpert MTB/RIF (Cepheid) with probeTEC (Becton-Dickinson) and Taqman MTB (Roche) for detection of TB bacteria20120 iqtibos
  4. Evaluation of the new, easy to perform, IS6110 based molecular assay Speed-oligo® Direct MTB (Vircell, Spain) for the detection of M. tuberculosis and direct comparison to probeTec (BD, USA)20120 iqtibos
  5. Comparison of Xpert MTB/RIF with ProbeTec ET DTB and COBAS TaqMan MTB for direct detection of M. tuberculosis complex in respiratory specimens20130 iqtibos
  6. Treatment Outcomes of Isoniazid-Resistant (Rifampicin Susceptible) Tuberculosis Patients in Uzbekistan, 2017–201820210 iqtibos
  7. Universal Access to Xpert MTB/RIF Testing for Diagnosis of Tuberculosis in Uzbekistan: How Well Are We Doing?20210 iqtibos
  8. Is Xpert MTB/Rif Ultra superior to Xpert MTB/Rif for the diagnosis of tuberculosis in children in Uzbekistan20210 iqtibos
  9. Tuberculosis diagnosis and the complete drug resistance pattern from a single sample within a single day by use of a composite platform of MAX MDR-TB and AmPORE-TB20260 iqtibos

Hammualliflar

  1. Harald Hoffmann5 ta umumiy asar2012–2026
  2. Sabine Hofmann-Thiel4 ta umumiy asar2012–2026
  3. Jamshid Gadoev4 ta umumiy asar2013–2021
  4. Nargiza Parpieva4 ta umumiy asar2021
  5. Uladzimir Antonenka3 ta umumiy asar2012–2013
  6. A Esenalieva3 ta umumiy asar2012–2013
  7. Dilyara Nabirova2 ta umumiy asar2021
  8. Sevak Alaverdyan2 ta umumiy asar2021
  9. Ajay Kumar2 ta umumiy asar2021
  10. Sanjar Sultanov2 ta umumiy asar2021

Barcha hammualliflar →